I thank the Senator. As she said, awareness of cardiovascular disease and strokes is important, as is the face, arms, speech and time, FAST, messaging. The main thing is to get to people quickly. I thank Senator Byrne for facilitating the opportunity to discuss this important matter of cardiovascular disease policy. I am taking this matter on behalf of the Minister, Deputy Carroll MacNeill, who cannot be here today. Cardiovascular disease encompasses a range of conditions, including heart attack and stroke. It remains a leading cause of death in Ireland and a significant contributor to hospital bed days in our hospitals. Ireland has made progress in tackling cardiovascular disease. Today, cardiovascular disease mortality is about half the level recorded in 1995, but this still accounts for 27.8% of all deaths in Ireland, which is something we are monitoring. The absolute number of cardiovascular disease cases has increased due to the rise in population and Ireland’s ageing demographics.
Work is ongoing to finalise priorities for the Irish Presidency of the Council of the European Union. It is envisaged that prevention, including for cardiovascular health, will be one of the themes of our Presidency programme. The Minister is saying this will be one of the priorities. Irish officials, working closely with EU colleagues, contributed to the development of a new Council conclusion on the improvement of cardiovascular health, adopted on 3 December 2024, marking a strong political commitment to tackling cardiovascular disease across Europe. On 16 December 2025, the European Commission published safe hearts, the EU cardiovascular plan, whish the Senator spoke about. It is a landmark initiative aimed at reducing premature deaths by improving prevention, early detection and treatment, while also driving innovation.
Ireland contributed to the OECD report, the State of Cardiovascular Health in the European Union, which provided an evidence base for the safe hearts plan as well as sharing a call for evidence with relevant stakeholders. Ireland’s active role in shaping these policies reflects our ambition to strengthen cardiovascular health outcomes for our population and contribute to a healthier Europe. On 8 April 2025, the national review of adult specialist cardiac services in Ireland was published. The comprehensive, evidence-based report provides 23 key recommendations on cardiac health policy. Department officials are now working closely with the HSE to progress the implementation of these recommendations. This is a complex, multi-year reform programme that will ensure a comprehensive and deliverable approach in achieving outcomes.
Cardiovascular health was prioritised in budget 2025, which allocated over €9 million in full-year funding to support vital cardiovascular initiatives. Budget 2025 allocated €4 million for full-year costs, and 45 whole-time equivalents, WTEs, to progress cardiac services. To date, 28 of these 45 WTEs have been prioritised. This investment facilitates the initial steps in cardiac services reform and will support the development of a new cardiovascular strategy as committed to in the programme for Government. In the short term, we will deliver enhanced cardiac services and develop the necessary structures to ensure success in the longer term.
With regard to services for stroke, the national stroke strategy was published in 2022 and over €13 million has been allocated to its implementation to date.
The stroke strategy aims to modernise our stroke services in line with Sláintecare and ensure the future readiness of services, given the ageing demographic and the predicted rise in stroke incidence in coming decades. The Government is committed to supporting our population screening programmes, which are a valuable part of our health service, enabling early treatment and care for many people and improving the overall health of our population.
The national screening advisory committee, NSAC, is the independent expert group that considers proposed changes to Ireland's screening programmes. The NSAC assesses the evidence in a robust and transparent manner to ensure that our screening programmes are effective, quality assured and operating to safe standards, and that the benefits of screening outweigh the harms. The NSAC has previously received proposals through its call-for-submission process, calling for the introduction of a screening programme for structural heart disease. After reviewing the submissions received, the NSAC decided not to refer the applications for further consideration by the Health Information and Quality Authority, HIQA, at this time.
In addition to population-based screening programmes, our GP chronic disease management programme is entering its sixth year of operation. This programme includes opportunistic screening for a range of cardiovascular and other risk factors when patients attend their GP with another condition. The programme has expanded its services based on its success to date. For example, familial hypercholesterolemia will be added to the list of risk factors screened this year.